PMID: 6107825Oct 1, 1980Paper

Selection of donors for bone marrow transplantation in childhood leukemia (author's transl)

Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft für Kinderheilkunde
E D AlbertD Schendel

Abstract

The problems of immunological donor selection for bone marrow transplantation (BMT) are discussed: In acute childhood leukemia, the possibility of BMT should be discussed already at the time of diagnosis, in case the orthodox treatment of leukemia is not successful. The tests for donor selection should best be done during the first remission and should include the antigens of HLA-A,B,C,DR and D-loci as well as the Bf and GLO-Systems. It is important to include in the tests as many as possible first degree relatives in order to establish the inheritance of the HLA-Antigens. If there is no HLA-genetically identical sibling, it also possible to consider other relatives, provided there is genetic identity for one HLA-Haplotype and chance-compatibility for the other haplotype.

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.